Intellia Therapeutics Inc.

NTLA | NASDAQ

Price Alert Chart Builder DCF Calculator

$12.63

+$0.41 (+3.36%)

Sep 22, 2026, 12:51 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-519.02M	-519.02M	-481.19M	-474.19M	-267.89M	-134.23M
Depreciation & Amortization	10.29M	10.29M	8.98M	7.57M	6.89M	6.31M
Stock-Based Compensation	154.27M	154.27M	134.05M	91.4M	47.01M	19.9M
Other Working Capital	-78.79M	-22.86M	-22.29M	-47.55M	-31.36M	49.98M
Other Non-Cash Items	79.34M	-6.3M	-3.47M	95.8M	2.94M	573K
Deferred Income Tax	n/a	n/a	n/a	n/a	8.93M	n/a
Change in Working Capital	-73.75M	11.88M	-52.45M	-53.87M	-22.9M	57.53M
Operating Cash Flow	-348.88M	-348.88M	-394.09M	-333.29M	-225.03M	-49.91M
Capital Expenditures	-5.78M	-5.78M	-13.99M	-58.39M	-12.76M	-3.59M
Cash Acquisitions	n/a	n/a	n/a	-44.68M	-3M	n/a
Purchase of Investments	-935.57M	-935.57M	-904.46M	-429.03M	-1.02B	-473.7M
Sales Maturities Of Investments	1.05B	1.07B	887.1M	647.58M	485.6M	262.8M
Other Investing Acitivies	20.97M	n/a	n/a	44.83M	n/a	n/a
Investing Cash Flow	125.57M	125.57M	-31.35M	160.31M	-550.78M	-214.49M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	54.26M	8.85M	10.53M	17.17M	43.12M	13.13M
Financial Cash Flow	185.75M	185.75M	130.32M	582.96M	736.69M	371.78M
Net Cash Flow	-37.57M	-37.57M	-295.11M	409.98M	-39.12M	107.38M
Free Cash Flow	-354.66M	-354.66M	-408.07M	-391.68M	-237.79M	-53.5M
Adj. Free Cash Flow	-508.93M	-508.93M	-542.12M	-483.08M	-284.8M	-73.4M
Maintenance CapEx	n/a	n/a	-13.99M	-29.25M	-12.76M	n/a
Growth CapEx	-5.78M	-5.78M	n/a	-29.14M	n/a	-3.59M
Owner Earnings	-348.88M	-348.88M	-408.07M	-362.54M	-237.79M	-49.91M